ABOS NASDAQ
Acumen Pharmaceuticals, Inc.
1W: -5.5%
1M: +16.3%
3M: +23.2%
YTD: +44.5%
1Y: +116.3%
3Y: -50.8%
5Y: -80.9%
$2.92
+0.06 (+2.10%)
Weekly Expected Move ±10.8%
$2
$3
$3
$3
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$210.9M
52W Range1.21-3.6
Volume318,175
Avg Volume426,217
Beta0.33
Dividend—
Analyst Ratings
Company Info
CEODaniel J. O'Connell
Employees61
SectorHealthcare
IndustryBiotechnology
IPO Date2021-07-01
Websiteacumenpharm.com
1210-1220 Washington St.
Newton, MA 02465
US
Newton, MA 02465
US
434 297 1000
About Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in Phase I clinical trials, where it is designed to specifically target soluble amyloid-beta oligomers. The firm was established in 1996 and maintains its principal headquarters in Charlottesville, Virginia.
Latest News
BlackRock Inc. Makes New Investment in Acumen Pharmaceuticals, Inc. $ABOS
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences
ADAR1 Capital Management LLC Makes New Investment in Acumen Pharmaceuticals, Inc. $ABOS
Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Porter Derrell | M-Exempt | 13,040 | $1.07 | 2026-06-17 |
| Porter Derrell | S-Sale | 13,040 | $2.33 | 2026-06-17 |
| Porter Derrell | M-Exempt | 13,040 | $1.07 | 2026-06-17 |
| Porter Derrell | S-Sale | 12,800 | $2.33 | 2026-06-16 |
| Porter Derrell | M-Exempt | 6,460 | $1.07 | 2026-06-15 |